{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BWK5",
      "entity_text" : "MRI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05325",
      "entity_text" : "MPIO-alphaVCAM-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Mardiquian et al. also demonstrated that MPIO-alphaVCAM-1 enhanced MRI could be used to monitor the efficacy of immunomodulatory treatment, as evidenced in mice receiving an anti-IL-17A treatment that presented lower levels of both neurological deficit and endothelial activation compared to control mice XREF_BIBR.",
  "reading_complete" : "2020-08-03T16:15:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:12:09Z",
  "trigger" : "enhanced",
  "evidence" : [ "MPIO-alphaVCAM-1 enhanced MRI" ],
  "pmc_id" : "5835930",
  "score" : 0
}